Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ecolibrium Biologicals has developed and commercialized Lateral WDG, a biopesticide containing Brevibacillus laterosporus strain 1951. This is the first global registration of this organism for lepidopteran pest control. The company focuses on sustainable alternatives to chemical pesticides for agricultural use and collaborates with leading research institutions in New Zealand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ecolibrium.